Covered recipient · General Payments record
ALVARO GALVEZ LIMA
Allopathic & Osteopathic Physicians Surgery
General Payments · PY2018–2024
$12,637.58
- Reported across 80 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $303.08 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $132.78 | 7 |
| Mozarc Medical US LLC | $100.00 | 1 |
| BAXTER HEALTHCARE | $27.50 | 1 |
| Phathom Pharmaceuticals, Inc. | $16.53 | 1 |
| Lilly USA, LLC | $13.66 | 1 |
| INTUITIVE SURGICAL, INC. | $12.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Baxter Healthcare | $27.50 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120658515 | CMS |
| INTUITIVE SURGICAL, INC. | $12.61 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137212375 | CMS |
| Lilly USA, LLC | $13.66 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136026410 | CMS |
| Mozarc Medical US LLC | $100.00 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141013134 | CMS |
| Novo Nordisk Inc | $8.48 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097795859 | CMS |
| Novo Nordisk Inc | $6.88 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097124939 | CMS |
| Novo Nordisk Inc | $7.66 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096614198 | CMS |
| Novo Nordisk Inc | $10.97 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096894014 | CMS |
| Novo Nordisk Inc | $69.99 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096569942 | CMS |
| Novo Nordisk Inc | $16.57 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097183776 | CMS |
| Novo Nordisk Inc | $12.23 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096715377 | CMS |
| Phathom Pharmaceuticals, Inc. | $16.53 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151063909 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.